Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001057951 | SCV001222480 | likely benign | not provided | 2024-12-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001155014 | SCV001316414 | uncertain significance | Usher syndrome type 2C | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Department of Otolaryngology – Head & Neck Surgery, |
RCV001375207 | SCV001571909 | uncertain significance | Hearing impairment | 2021-04-12 | criteria provided, single submitter | clinical testing | PM2_Supporting, PP3_Supporting |
Gene |
RCV001057951 | SCV001804076 | uncertain significance | not provided | 2024-10-24 | criteria provided, single submitter | clinical testing | Reported in a patient with generalized epilepsy and CPVT in published literature (PMID: 29261713); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30602096, 36484990, 29261713) |
Fulgent Genetics, |
RCV002479352 | SCV002782338 | uncertain significance | Usher syndrome type 2C; Febrile seizures, familial, 4 | 2021-09-09 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001057951 | SCV004159100 | uncertain significance | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | ADGRV1: PM2 |
Breakthrough Genomics, |
RCV001057951 | SCV005189049 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001057951 | SCV001951932 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001057951 | SCV001975197 | uncertain significance | not provided | no assertion criteria provided | clinical testing |